Jesus Novalbos

Madrid, MD 28006, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

BioFRAM PGx, an Implementation Proposal for Pharmacogenetics in the Spanish National Health System.

BioFRAM PGx, an Implementation Proposal for Pharmacogenetics in the Spanish National Health System.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 02, 2026

Genomic and Sex Contributions to Interindividual Variability in Pitavastatin Bioavailability.

Genomic and Sex Contributions to Interindividual Variability in Pitavastatin Bioavailability.

Journal: Basic & clinical pharmacology & toxicology

Published: April 13, 2026

Impact of CYP and ABCB1 Polymorphisms on Bortezomib-Induced Adverse Events in Multiple Myeloma.

Impact of CYP and ABCB1 Polymorphisms on Bortezomib-Induced Adverse Events in Multiple Myeloma.

Journal: Biomedicines

Published: March 04, 2026

An Overview of Endometriosis and Potential Pharmacogenetic Targets.

An Overview of Endometriosis and Potential Pharmacogenetic Targets.

Journal: Pharmaceutical research

Published: December 16, 2025

Corrigendum to "Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter" [Biomed. Pharmacother. 193 (December) (2025) 118732].

Corrigendum to "Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter" [Biomed. Pharmacother. 193 (December) (2025) 118732].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 15, 2025

The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review.

The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review.

Journal: Pharmacogenomics

Published: August 21, 2025

Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter.

Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 19, 2025

Effect of Genetic Variants on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Involvement of ABCG2, SLCO1B1 and NAT2.

Effect of Genetic Variants on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Involvement of ABCG2, SLCO1B1 and NAT2.

Journal: International journal of molecular sciences

Published: November 27, 2024

Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice.

Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice.

Journal: Actas dermo-sifiliograficas

Published: September 12, 2024

Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics.

Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics.

Journal: Frontiers in pharmacology

Published: April 08, 2024

Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice.

Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice.

Journal: Experimental dermatology

Published: April 06, 2024

Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials.

Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials.

Journal: Frontiers in pharmacology

Published: February 22, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026